Refresh

Natco Pharma Ltd. - Research Center

524816 NATCOPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
Expenses

Material consumed

567.10 570.10 528.10 426.00 376.30

Manufacturing expenses

81.90 76.40 59.40 62.40 59.60

Personnel expenses

425.70 410.10 380.00 356.10 340.20

Selling expenses

- - - - -

Adminstrative expenses

431.60 498.20 268.40 367.70 393.70

Expenses capitalised

- - - - -

Cost of sales

1,506.30 1,554.80 1,235.90 1,212.20 1,169.80

Operating profit

844.70 213.00 417.60 578.00 816.50

Other recurring income

85.50 94.60 101.10 123.80 129.80

Adjusted PBDIT

930.20 307.60 518.70 701.80 946.30

Financial expenses

8.60 13.30 11.30 20.60 18.80

Depreciation

150.90 138.40 115.20 98.10 80.10

Other write offs

- - - - -

Adjusted PBT

770.70 155.90 392.20 583.10 847.40

Tax charges

133.60 16.80 82.70 108.60 180.30

Adjusted PAT

637.10 139.10 309.50 474.50 667.10

Non recurring items

1.70 9.80 -0.30 -5.20 -

Other non cash adjustments

- - - - -

Reported net profit

638.80 148.90 309.20 469.30 667.10

Earnigs before appropriation

3,225.90 2,668.90 2,631.70 2,476.10 2,138.00

Equity dividend

100.40 82.10 113.90 101.20 73.00

Preference dividend

- - - - -

Dividend tax

- - - 26.20 18.90

Retained earnings

3,125.50 2,586.80 2,517.80 2,348.70 2,046.10
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com